Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Summary

Current therapies for Non-Hodgkin's Lymphoma provide limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Non-Hodgkin's Lymphoma. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Non-Hodgkin's Lymphoma.

Timeline

Start

1997-10-13

Primary completion

2007-02-02

Completion

2007-02-02

Drugs

Indications